Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.070
+0.020 (0.66%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $253.38 million as of March 30, 2026. Its market cap has increased by 371.71% in one year.
Market Cap
253.38M
Enterprise Value
167.96M
1-Year Change
371.71%
Ranking
Category
Stock Price
$3.07
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $253.38M, a decrease of -68.59%. That is a compound annual growth rate of -18.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 251.73M | 5.35% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 267.18M |
| Foghorn Therapeutics | 264.15M |
| LENZ Therapeutics | 263.38M |
| Anavex Life Sciences | 261.33M |
| Sol-Gel Technologies | 258.90M |
| Orchestra BioMed Holdings | 249.30M |
| Enlivex | 249.25M |
| Abeona Therapeutics | 244.74M |